1.Surgical correction of penoscrotal transposition with hypospadias: experience with 83 cases.
Abudureyimu ABUDUSAIMI ; Liang-feng TANG ; Shuang-sui RUAN ; Xiang WANG
National Journal of Andrology 2011;17(2):143-145
OBJECTIVETo investigate the techniques of surgical correction of penoscrotal transposition with hypospadias.
METHODSWe retrospectively studied 83 cases of penoscrotal transposition with hypospadias treated by surgery from January 2003 to June 2009, and analyzed the surgical techniques and follow-up results.
RESULTSThe patients underwent urethroplasty with simultaneous or staged surgical correction of penoscrotal transposition. Postoperative follow-up was conducted for 0.5-5 years. Eighty-one of the patients were satisfied with the appearance of the reconstructed penis and scrotum, and satisfactory outcomes were achieved in the other 2 with severe hypospadias after a second surgical correction of penoscrotal transposition.
CONCLUSIONUrethroplasty with simultaneous or staged surgical correction of penoscrotal transposition is recommendable for its resultant penile straightness, desirable penoscrotal appearance, good surgical prognosis and few postoperative complications.
Abnormalities, Multiple ; diagnosis ; surgery ; Child ; Child, Preschool ; Humans ; Hypospadias ; complications ; diagnosis ; surgery ; Infant ; Male ; Penis ; abnormalities ; surgery ; Retrospective Studies ; Scrotum ; abnormalities ; surgery ; Treatment Outcome ; Urethral Diseases ; complications ; diagnosis ; surgery
2.In vitro study of platelet glycoprotein monoclonal antibody eluting stents.
Lai-long LUO ; Gui-xue WANG ; Tie-ying YIN ; Shi-sui LUO ; Chang-gen RUAN ; Yan-bin HOU
Chinese Journal of Medical Instrumentation 2006;30(3):163-166
In order to prove the feasibility of preparation of the drug-incorporated stent by immersing stent wires in the monoclonal antibody (mAb) solution, fluorescence stain and image analysis were used to evaluate the L-PLA-coated stent. Absorption was measured using a radioisotope technique after preparing the mAb-incorporated stent, and the absorption curve was determined from the absorption data. In an in vitro perfusion circuit, the antibody was eluted from the stent matrices, and the related influence factors were evaluated based on the release data.
Absorption
;
Alloys
;
chemistry
;
Antibodies, Monoclonal
;
chemistry
;
immunology
;
Drug-Eluting Stents
;
Graft Occlusion, Vascular
;
immunology
;
prevention & control
;
Humans
;
Lactic Acid
;
chemistry
;
Platelet Aggregation Inhibitors
;
chemistry
;
immunology
;
Platelet Glycoprotein GPIIb-IIIa Complex
;
immunology
;
Polymers
;
analysis
;
chemistry
;
Time Factors
3.Double-blind, placebo-controlled, randomized, multicenter studies of oxiracetam in the treatment of brain injury
Cheng-Yi LUO ; Yi-Quan KE ; Ru-Xiang XU ; Xiang ZHANG ; Jian-Wen GU ; Ru-Tong YU ; Sui-Ruan WANG ; Zhi-Gang WANG ; Kai-Xuan LU ; Shun WAN
Chinese Journal of Neuromedicine 2011;10(2):192-196
Objective To evaluate the efficacy and safety of oxiracetam in the treatment of neurological deficits resulting from brain injury through the comparison of oxiracetam for injection and piracetam for injection in clinical trials. Methods A multiple-center, randomized, double-blind,parallel study was performed on 239 patients; these patients were divided into experimental group (oxiracetam for injection, n=120) and control group (piracetam, n=119). National institutes of health stroke scale (NIHSS), Glasgow coma scale (GCS), myodynamia grading, mini-metal state examination (MMSE) were employed to evaluate the therapeutic effects; electrocardiogram and laboratory examination were performed, and the side effects were also observed. Results The scores of NIHSS,GCS and myodynamia grading after treatment in the 2 groups were all significantly higher than those before treatment (P<0.05); however, no significant differences on these scores were noted between the experimental group and control group (P>0.05). No serious adverse events were noted in both groups.Conclusion Oxiracetam, the same as piracetam, is safe and effective in the treatment of neurological deficits secondary to brain injury.
4.Diagnosis and treatment of ovotesticular disorders of sex development in children.
Liang-Sheng LU ; Shuang-Sui RUAN ; Yun-Li BI ; Yi-Qun LU ; Xiang WANG ; Lin-Juan GE ; Xian-Min XIAO
National Journal of Andrology 2009;15(7):628-631
OBJECTIVETo investigate the diagnosis and treatment of ovotesticular disorders of sex development (DSD) in children.
METHODSWe reviewed the clinical data of 9 cases of ovotesticular DSD admitted in our department from 1988 to 2007.
RESULTSThe patients ranged in age from 9 months to 9 years, 7 raised as males and 2 as females. As for the karyotype, 4 cases were 46,XX, 2 were 46,XX/46,XY, 1 was 46,XY, and the other 2 had no karyotype data. All of them presented with obscure external genitalia: perineal or penoscrotal hypospadias with or without cryptorchidism in males and hypertrophy of the clitoris in females. They were diagnosed with ovotesticular DSD by gonad biopsy and underwent genitoplasty.
CONCLUSIONThe gender assignment of the ovotesticular DSD patient was chiefly based on the development of external genitalia, dominant gonad, karyotype and the parent's will. Laparoscopic technology is recommended in gonad biopsy and orchiopexy during the treatment of ovotesticular DSD.
Child ; Child, Preschool ; Disorders of Sex Development ; diagnosis ; surgery ; Female ; Humans ; Infant ; Laparoscopy ; Male ; Retrospective Studies ; Sexual Development
5.Chinese expert consensus on diagnosis, treatment and prevention of venous thrombus embolism associated with chest trauma (2022 version)
Kaibin LIU ; Yi YANG ; Hui LI ; Yonten TSRING ; Zhiming CHEN ; Hao CHEN ; Xinglong FAN ; Congrong GAO ; Chundong GU ; Yutong GU ; Guangwei GUO ; Zhanlin GUO ; Jian HU ; Ping HU ; Hai HUANG ; Lijun HUANG ; Weiwei HE ; Longyu JIN ; Baoli JING ; Zhigang LIANG ; Feng LIN ; Wenpan LIU ; Danqing LI ; Xiaoliang LI ; Zhenyu LI ; Haitao MA ; Guibin QIAO ; Zheng RUAN ; Gang SUI ; Dongbin WANG ; Mingsong WANG ; Lei XUE ; Fei XIA ; Enwu XU ; Quan XU ; Jun YI ; Yunfeng YI ; Jianguo ZHANG ; Dongsheng ZHANG ; Qiang ZHANG ; Zhiming ZHOU ; Zhiqiang ZOU
Chinese Journal of Trauma 2022;38(7):581-591
Chest trauma is one of the most common injuries. Venous thromboembolism (VTE) as a common complication of chest trauma seriously affects the quality of patients′ life and even leads to death. Although there are some consensus and guidelines on the prevention and treatment of VTE at home and abroad, the current literatures lack specificity considering the diagnosis, treatment and prevention of VTE in patients with chest trauma have their own characteristics, especially for those with blunt trauma. Accordingly, China Chest Injury Research Society and editorial board of Chinese Journal of Traumatology organized relevant domestic experts to jointly formulate the Chinese expert consensus on the diagnosis, treatment and prevention of chest trauma venous thromboembolism associated with chest trauma (2022 version). This consensus provides expert recommendations of different levels as academic guidance in terms of the characteristics, clinical manifestations, risk assessment, diagnosis, treatment, and prevention of chest trauma-related VTE, so as to offer a reference for clinical application.